Thursday, May 23, 2013 1:43 AM EST

GlaxoSmithKline

Overview

GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.

It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

Headlines Around the Web

Glaxo to sell Ribena and Lucozade

Apr 25 - Independent

GlaxoSmithKline faces inquiry over 'price fixing'

Apr 20 - Independent

GlaxoSmithKline accused of paying competitors to delay drug

Apr 20 - CBC

GlaxoSmithKline accused of deal to delay release of generic versions of drug

Apr 19 - Independent

GlaxoSmithKline accused of deal to delay release of generic versions of anti-depressant drug

Apr 19 - Independent

London Markets: GSK, Evraz rise in upbeat U.K. market

Apr 18 - MarketWatch

Leading UK companies cut rewards of chief executives

Mar 07 - Independent

Movers & Shakers: Monday movers: 3-D printers, China property

Mar 05 - MarketWatch

Glaxo review could see it sell Ribena and Lucozade

Feb 07 - Independent

London Markets: Resource firms boost FTSE 100, GSK rises

Jan 29 - MarketWatch

GSK in $150m US settlement

Dec 20 - Independent

GSK's boost in Nigeria and India

Nov 27 - Independent

Glaxo sells 25 brands to Aspen

Aug 16 - Independent

GlaxoSmithKline return to sales growth is held back by austerity-led price pressure

Jul 26 - Independent

HGS shareholders vow to challenge takeover by GSK

Jul 17 - Independent

GSK wins $3.0-bln takeover of Human Genome Sciences

Jul 17 - France24

Infosys first quarter profit rises 33%, meets forecast

Jul 12 - The Times of India

Barclays shows watchdogs need more teeth

Jul 07 - Financial Times

Al Lewis: How to sell drugs to children

Jul 05 - MarketWatch

£1.9bn fraud fine for Glaxo in US sparks calls for UK prosecution

Jul 04 - Independent

Articles About GlaxoSmithKline

Elan strikes more deals, agrees second share buyback

By Reuters

Irish drug firm Elan agreed on Monday to buy two private drug firms, spin-off its one experimental drug and buy back more shares to give a firmer idea of how the company will be reconfigured as shareholders weigh up a takeover bid. (May 20)

MORE TOPICS: DUBAI, NEW YORK, INVESTMENT

India Develops Low-Cost Diarrhoea Vaccine For Children Against Rotavirus, Mass Production Expected in 8 Months

Rotavirus Cure: India Develops Low-Cost Vaccine for Children, Mass Production Expected in 8 Months

By IBTimes AU

A low-cost diarrhoea vaccine for children has been developed by India, enabling parents all over the world to avail of a cheaper alternative medicine that could cure and save their children from the deadly Rotavirus. (May 16)

Wall Street ends near flat after recent gains; healthcare climbs

By Reuters

Stocks ended flat on Monday, pausing after hitting record highs last week, but strength in healthcare issues helped to keep declines in check. (May 14)

MORE TOPICS: DOW JONES, RETAIL SALES, RETAIL, NEW YORK

Wall Street flat after retail sales, Nasdaq edges higher

By Reuters

U.S. stocks were mostly flat on Monday as investors paused following a rally that took indexes to record highs, though a strong read on retail sales limited declines and the Nasdaq ticked up on a rally in Netflix. (May 14)

MORE TOPICS: NETFLIX, CHINA, DOW JONES, CRUDE OIL, RETAIL SALES, RETAIL

US STOCKS-Wall St dips but rise in retail sales limits decline

By Reuters

U.S. stocks edged lower on Monday as investors paused following a rally that took indexes to record highs, though a strong read on retail sales limited declines. (May 14)

MORE TOPICS: NETFLIX, CHINA, DOW JONES, CRUDE OIL, RETAIL SALES, RETAIL

Wall Street dips but rise in retail sales limits decline

By Reuters

U.S. stocks dipped on Monday, retreating from the most recent record high, but an unexpected rise in retail sales last month muted declines. (May 14)

MORE TOPICS: DOW JONES, RETAIL SALES, RETAIL, NEW JERSEY

Wall Street set to dip at open after record high

By Reuters

U.S. stocks were poised for a lower open on Monday after the S&P 500 index closed at a record high, but an unexpected rise in retail sales last month was likely to curb any decline. (May 13)

MORE TOPICS: DOW JONES, RETAIL SALES, RETAIL, NEW JERSEY

Stock futures dip after record high; retail sales on tap

By Reuters

Stock index futures dipped on Monday, indicating the S&P 500 may retreat from its most recent record high, ahead of data on retail sales. (May 13)

MORE TOPICS: CHINA, DOW JONES, COMMERZBANK, RETAIL SALES, RETAIL, BIRD FLU

BSE Sensex Gains; Blue Chips Up On Strong FII Flows

By Reuters

The BSE Sensex gains 0.54 percent, while the broader Nifty is 0.53 percent higher, trading above the key 6,000 level. (May 07)

JP Morgan, Greenhill advising GSK on sale of soft drinks brands

By Reuters UK

JP Morgan <JPM.N> and Greenhill <GHL.N> have been appointed to advise GlaxoSmithKline <GSK.L> on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds. (May 02)